SCHEMBL7127946

SCHEMBL7127946

Nc1sc2c(c1C(=O)O)OC(CN1C(=O)c3ccccc3C1=O)CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
ADORA1 P30542 1/20 0.38
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KEAP1 Q14145 2/20 0.35
KDM4E B2RXH2 2/20 0.35
KMT2A Q03164 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
MMP1 P03956 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316711 0.77 CYP1A2 (0.44) ALDH1A1CYP2C9CYP1A2CYP2C19ADORA1
SCHEMBL7681582 0.77 EPHX2 (0.38) ALDH1A1CYP2C9CYP1A2CYP2C19GAA
SCHEMBL5844714 0.72 ALDH1A1 (0.40) ALDH1A1CYP2C9CYP1A2CYP2C19GAA
SCHEMBL9170071 0.71 CYP2C9 (0.59) ALDH1A1CYP2C9CYP1A2CYP2C19CASP1
SCHEMBL7861190 0.70 CYP1A2 (0.42) ALDH1A1CYP2C9CYP1A2CYP2C19ADORA1
SCHEMBL6049947 0.69 ADORA1 (0.44) ALDH1A1CYP2C9CYP1A2CYP2C19ADORA1
SCHEMBL7490590 0.67 KEAP1 (0.45) ALDH1A1ADORA1KEAP1NFE2L2
SCHEMBL8858326 0.67 ALDH1A1 (0.47) ALDH1A1CYP2C9CYP1A2CYP2C19GAA
SCHEMBL5838365 0.66 CYP1A2 (0.40) ALDH1A1CYP2C9CYP1A2CYP2C19ADORA1
SCHEMBL7004595 0.66 ADORA1 (0.40) ALDH1A1CYP2C19ADORA1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) MOLLER NIELS PETER HUNDAHL (DK) 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRA ALDH1A1 3737/4885CYP2C9 3024/4885CYP1A2 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.